Disease management

The AI platform can predict a person's risk of having a stroke or a heart attack in the next five years.

The AI system can also classify abnormal tissues as malignant or benign.  

The telemedicine platform will start by offering diabetes care support.

The companies said their long-term goal is to develop and offer more digital health tools "through a multi-partner ecosystem" as well as advocate for reimbursement options.

The clearance represents what could be the world's first regulatory approval of a DTx app for hypertension treatment.

Also: Butterfly Network reports a year-over-year revenue increase of more than 25%, with a $44.5 million net loss, and One Medical announces a significant jump in revenue.

Under the deal, MedRhythms would receive a $3 million upfront payment and could earn up to $117.5 million if certain milestones are met.

Also: Pediatric behavioral health company Brightline partners with a youth health education nonprofit to develop teen programs, and digital fitness startup FitOn launches courses for seniors and people with chronic conditions.

The AI tech can spot signs of pancreatic cancer from non-contrast CT images.

The round comes nearly a year after the company announced it had raised $45 million in Series C financing.